---
layout: default
title: Farhana Islam
description: Curriculum Vitae
---

## Education

| **Doctor of Philosophy (Ph.D.)**, Pharmacology   | Department of Pharmacology & Toxicology,<br />_University of Toronto, Toronto, ON._ |
| **Master of Science (M.Sc.)**, Neuroscience      | Centre for Neuroscience Studies,<br />_Queen’s University, Kingston, ON._           |
| **Bachelor of Science (Honours) (H.B.Sc.)**,<br />Neuroscience and Biochemistry majors, Psychology minor | University of Toronto - St. George Campus, Toronto, ON


* * *

## Publications

**Islam, F.**, Marshe, V.S., Magarbeh, L., Frey, B.N., Milev, R.V., Soares, C., Parikh, S., Placenza, F., Strother, S.C., Hassel, S., Taylor, V.H., Leri, F., Blier, P., Uher, R., Farzan, F., Lam, R.W., Turecki, G., Foster, J.A., Rotzinger, S., Kennedy, S.H., Müller, D.J. (2022) [Effects of CYP2C19 and CYP2D6 Gene Variants on Escitalopram and Aripiprazole Treatment Outcome and Serum Levels: Results from the CAN-BIND 1 Study](https://www.nature.com/articles/s41398-022-02124-4). Translational Psychiatry. 12, 366.

**Islam, F.**, Hain, D., Lewis, D., Law, R., Brown, L., Tanner, J-A., & Müller, D.J. (2022) [Pharmacogenetics of Clozapine-induced Agranulocytosis: A Systematic Review and Meta-Analysis](https://www.nature.com/articles/s41397-022-00281-9). The Pharmacogenomics Journal. DOI: 10.1038/s41397-022-00281-9

**Islam, F.**, Men, X., Yoshida, K., Zai, C.C., & Müller, D.J. (2021) [Pharmacogenetics-guided advances in antipsychotic treatment](https://pubmed.ncbi.nlm.nih.gov/34129738/). Clinical Pharmacology and Therapeutics. 110(3), 582-588.

**Islam, F.**, Gorbovskaya, I., & Müller, D.J. (2021) [Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. In: Kim YK. (eds) Major Depressive Disorder](https://pubmed.ncbi.nlm.nih.gov/33834403/). Advances in Experimental Medicine and Biology, vol 1305. Springer, Singapore. 

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. (2021) [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://pubmed.ncbi.nlm.nih.gov/33143542/). Journal of Psychopharmacology. 35(1), 31-39.

Marshe, V.S., Maciukiewicz, M., Hauschild, A-C., **Islam, F.**, Qin, L., Tiwari, A.K., Sibille, E., Blumberger, D.M., Karp, J.F., Flint, A.J., Kennedy, S.H., Lam, R.W., Frey, B., CAN-BIND Investigator Team, Kennedy, J.L., Mulsant, B.H., Reynolds III, C.F., Lenze, E.J., & Müller, D.J. (2021) [Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response](https://www.nature.com/articles/s41398-021-01248-3). Translational Psychiatry. 11(1), 1-12. 

Marshe, V.S., **Islam, F.**, Maciukiewicz, M., Fiori, L.M., Yerko, V., Yang, J., Turecki, G., Foster, J.A., Kennedy, S.H., Blumberger, D.M., Karp, J.F., Kennedy, J.L., Muslant, B.H., Reynolds, C.F. 3rd, Lenze, E.J., & Müller, D.J. (2020) [Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine](https://pubmed.ncbi.nlm.nih.gov/31954757/). Progress in Neuro-Psychopharmacology & Biological Psychiatry. 100, 109867.

Marshe, V.S., **Islam, F.**, Maciukiewicz, M., Bousman, C., Eyre, H.A., Lavretsky, H., Muslant, B.H., Reynolds, C.F. 3rd, Lenze, E.J., & Müller, D.J. (2020) [Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions](https://pubmed.ncbi.nlm.nih.gov/32122803/). American Journal of Geriatric Psychiatry. 28(6), 609.

**Islam, F.**, Voineskos, A., Mulsant, B.H., & Rajji, TK. [Expression of brain derived neurotrophic factor in individuals with schizophrenia and healthy aging: testing the accelerated aging hypothesis in schizophrenia](https://pubmed.ncbi.nlm.nih.gov/28534294/). (2017) Current Psychiatry Reports. 19 (7), 36.

**Islam, F.**, Xu, K., & Beninger, R.J. [Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference](https://pubmed.ncbi.nlm.nih.gov/28284949/). (2017) Behavioural Brain Research. 326, 217-225.

* * *

## Selected Honours and Awards


2017, 2022.       | Department of Pharmacology & Toxicology Book Fund Travel Award, _University of Toronto_
2021	            | Early Career Investigator Award for the 2021 World Congress of Psychiatric Genetics (WCPG), _International Society of Psychiatric Genetics (ISPG)_
2021, 2020, 2018	| Ontario Graduate Scholarship (3x), _Ministry of Colleges and Universities_
2019, 2017, 2016	| University of Toronto Fellowship (3x), _University of Toronto_
2019	            | Catherall Travel Bursary, _Massey College, University of Toronto_
2017, 2018	      | Massey College Junior Fellowship (2x), _Massey College, University of Toronto_
2017	            | Pharmacology Graduate Student Award, _University of Toronto_
2017	            | Frist-Jus Annual Memorial Award in Neuropsychopharmacology, _University of Toronto_
2014, 2015	      | Clifton Foundation Scholarship (2x), _Pathways to Education_
2014, 2015	      | Queen’s Graduate Award (2x), _School of Graduate Studies, Queen’s University_


* * *

## Teaching Experiences

|2017-Present         | Teaching Assistant    | _University of Toronto_ |
|* **Biostatistics I** (CHL5201Y), _Dalla Lana School of Public Health_ 
* **Biometrics** (BIO360H), _Department of Biology at the Mississauga Campus_ 
* **Pharmacology and Toxicology in Society** (PCL389H), _Department of Pharmacology and Toxicology_ 
* **Personalized Medicine** (PHM360H), _Department of Pharmacy_|

|2014-2017            | Teaching Assistant   | _Queen's University_     |
|* **Abnormal Psychology** (PSYC 235), _Department of Psychology_ 
* **Social Psychology** (PSYC 241), _Department of Psychology_|

* * *


## Invited Talks

|12 Oct 2021         | Effects of CYP2C19 and CYP2D6 Gene Variants on Escitalopram and Aripiprazole Treatment Outcome and Serum Levels: Results from the CAN-BIND 1 Study    | **WCPG Symposium: Moving Depression Pharmacogenetics Forward: Using Scientific Discoveries to Inform Clinical Decisions**, _2021 World Congress of Psychiatric Genetics (WCPG)_, Virtual|
|10 May 2019         | Association of CYP2C19 and CYP2D6 Gene Variants and Plasma Levels of Escitalopram and Aripiprazole with Treatment Outcome in the CAN-BIND-1 Sample.    | **Neurogenetics Lab Meeting**, _Centre for Addictions and Mental Health (CAMH)_, Toronto, ON|
|July 2016         | A role for Wnt Signalling in the cellular mechanisms underlying incentive learning.    | **Behavioural Neuroscience Summer Seminar Series**, _Queen's University_, Kingston, ON|


* * *

## Professional Development

Sept 2020      | **Machine Learning**, _Canadian Bioinformatics Workshop, Virtual_            | Workshop on machine learning and its application to bioinformatics: Decision Trees and Random Forests, Artificial Neural Networks (ANNs), and Hidden Markov Models (HMMs).<br /> [Certificate](https://drive.google.com/file/d/1nybmlzAISLhkSkE9pKz-31lj5WfJuQXX/view)
August 2018   | **Towards Pharmacogenomics in Clinic**, _U-PGx Summer School, Bonn, Germany_  | Summer school on the fundamentals of pharmacogenomics and its applications


* * *

## Mentorship

2019 - 2020     | **Pharmacology Graduate Student Association (PGSA)**, _University of Toronto_           |
|* Met with mentees (two 1st year PhD students) to provide guidance on navigating graduate school, building student-supervisor working relationships, meeting program requirements, accessing resources on campus, and additional support where necessary.|

Jan - May 2019  | **Student Experience Mentorship Program**, _Student Life, University of Toronto_        | 
|* Mentored a staff member and shared what it is like to be a student at U of T through one-one-one meetings and group mentorship activities/training.|

Jan - June 2018 | **Protégée Program**, _City of Toronto_                                                 | 
|* Selected to be a protégée of City Councillor Lucy Troisi of Ward 28 in this competitive program organised by the City of Toronto. I worked closely with Councillor Troisi on creating and editing a community newspaper for the inner-city community of St. James Town, and liaised with and interviewed groups and individuals within the community newsletter.|

Jan - June 2018 | **Women in House**, _Massey College_                                                    | 
|* I was selected to shadow Senator Salma Ataullahjan at Parliament Hill in Ottawa and learn more about what it means to be a female politician in Canada, especially as a Muslim woman of colour.|

* * *

## Professional Memberships

2021 - Present                  | Member            |  American Society for Clinical Pharmacology and Therapeutics (ASCPT)
2019 - Present                  | Junior Member     |  Canadian College of Neuropsychopharmacology (CCNP)
2019 - Present                  | Member            |  Pharmacogenomics Research Network (PGRN)

* * *

## Conference Presentations

### Symposium

**Islam, F.**, Marshe, V.S., .., S., Kennedy, S.H., Müller, D.J. Association of CYP2C19 and CYP2D6 genotypes and plasma levels of escitalopram and aripiprazole with treatment outcome in the CAN-BIND-1 sample. Talk presented at symposium: Moving Depression Pharmacogenetics Forward-Using Scientific Discoveries to Inform Clinical Decisions at the _World Congress of Psychiatry Genetics (WCPG)_, 12 October 2021; Virtual.

### Posters

**Islam, F.**, Magarbeh, L, .., S., Kennedy, S.H., Müller, D.J. . [Effects of CYP2C19, CYP2D6, and ABCB1 gene variants on escitalopram and aripiprazole treatment-related sexual side effects: results from the CAN-BIND-1 study](https://www.researchgate.net/publication/363833088_EFFECTS_OF_CYP2C19_CYP2D6_AND_ABCB1_GENE_VARIANTS_ON_ESCITALOPRAM_AND_ARIPIPRAZOLE_TREATMENT-RELATED_SEXUAL_SIDE_EFFECTS_RESULTS_FROM_THE_CAN-BIND-1_STUDY). _World Congress of Psychiatry Genetics (WCPG)_, 15 September 2022; Florence, Italy.

**Islam, F.**, Hain, D., Lewis, D., Law, R., Brown, L., Tanner, J-A., & Müller, D.J. [Genetic Determinants of Clozapine-Induced Agranulocytosis: A Systematic Review and Meta-Analysis](https://www.biologicalpsychiatryjournal.com/article/S0006-3223(21)00955-0/fulltext). Poster at the 76th Annual Meeting of the _Society of Biological Psychiatry_, 30 April 2021; Virtual.

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://pubmed.ncbi.nlm.nih.gov/33143542/). Poster at the _World Congress of Psychiatry Genetics (WCPG)_, 20 October 2020; Virtual.

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://journals.sagepub.com/doi/full/10.1177/0269881120946288). Poster at the 75th Annual Meeting of the _Society of Biological Psychiatry_, 30 April 2020; New York City, NY. Conference cancelled.

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. Effects of CYP1A2 and Cholinergic Receptor Muscarinic 1 (CHRM1) Gene Polymorphisms on Plasma Ratio of Clozapine/N-desmethylclozapine and Working Memory Performance in Schizophrenia. Poster presented at the _Canadian College of Neuropsychopharmacology 2019 Annual Meeting_, 14 June 2019; Montreal, QC.

**Islam, F.**, Marshe, V.S., Maciukiewicz, A., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Association of CYP2C19 and CYP2D6 genotypes and plasma levels of escitalopram and aripiprazole with treatment outcome in the CAN-BIND-1 sample. Poster presented at the Pharmacogenetic Research Network Meeting at the _American Society for Human Genetics_ Annual Meeting, 17 October 2019; Houston, TX.

**Islam, F.**, Marshe, V.S., Maciukiewicz, M., Lisoway, A., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Effects of CYP2C19 and CYP2D6 gene polymorphisms and methylation on plasma levels of escitalopram and aripiprazole and treatment outcome in the CAN-BIND-1 sample. Poster presented at the _Clinical Pharmacogenetics Implementation Consortium (CPIC®) Meeting_, 6 June 2019; Memphis, TN.

**Islam, F.**, Marshe, V.S., Maciukiewicz, M., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Association of CYP2C19 and CYP2D6 genotypes and plasma levels of escitalopram and aripiprazole with treatment outcome in the CAN-BIND-1 sample. Poster presented at the _World Federation of Societies of Biological Psychiatry (WFSBP)_ 14th World Congress of Biological Psychiatry, 5 June 2019; Vancouver, BC.

**Islam, F.**, Marshe, V.S., Maciukiewicz, M., Yoshida, K., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the CAN-BIND Cohort. Poster presented at the 74th Annual Meeting of the _Society of Biological Psychiatry_, 18 May 2019; Chicago, IL.

Yoshida, K., **Islam, F.**, Marshe, V.S., Maciukiewicz, M., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the CAN-BIND Cohort. Poster presented at the 57th Annual Meeting of the _American College of Neuropsychopharmacology_, 10 December 2018, Orlando, FL.

**Islam, F.**, Xu, K., and Beninger, R.J. Inhibition of Wnt signalling dosedependently impairs the acquisition and expression of amphetamine induced conditioned place preference. Poster presented at the _Society for Neuroscience_; 14 Nov 2016; San Diego, CA.

**Islam, F.**, and Beninger, R.J. Wnt inhibitor, IWP2, impairs expression of amphetamine produced conditioned place preference in rats. Poster presented at: 10th Annual CAN Meeting, _Canadian Association for Neuroscience_; 1 Jun 2016; Toronto, ON.

* * *

## Service and Outreach

2022 - Present;<br />2018-2019  | **Appointed Member** (2 terms)                            | ***University of Toronto Tribunal**, _University of Toronto_ |

|* As a member on the tribunal panel, heard cases of sensitive nature relating to academic misconduct and made impartial decisions on the evidence presented. |

2022 - Present;<br />2018-2019  | **Appointed Member** (2 terms)                            | **University Affairs Board, Office of the Governing Council**, _University of Toronto_ |

|* Represented students directly to the University in considering policy of a non-academic nature and matters that directly concern the quality of student and campus life.
|* Advocated for university policies that reflect the needs of students for inclusive and accessible non-academic services.|

2022 - Present;<br />2018-2019  | **Elected Member**                            | **Board of Directors**, _University of Toronto's Graduate Student's Union (UTGSU)_ |

|* As a Director on the Board, made decisions on the management and governance of the UTGSU that's in the best interest of its members. |

2021 - Present                  | **President (previously Vice President - elected)**       | **Tenants’ Association**, _University Family Housing, University of Toronto_ | 

|* Advocate on behalf of residents living at UFH directly to building management to resolve collective issues and improve living conditions for students and their families.|

2020 - Present                  | **Committee Member**                                        | **Equity, Diversity and Inclusion (EDI) Committee**, _Canadian College of Neuropsychopharmacology (CCNP)_ | 

|* Serve as a Member of the EDI committee for the CCNP actively working to create a more inclusive College where there is equal opportunity for and treatment of all meeting participants and staff.|

2020 - 2021                  | **Student Advisor**                                             | **Housing Services Student Advisory Committee**, _Student Life, University of Toronto_ |

|* Provide input and feedback on matters pertaining to housing services, programming for students, resources and departmental budget priorities.|
|* Advocate for affordable housing options for students and their families on campus.|

2019 - 2020                  | **Internal Liason Officer (elected)**                            | **Executive Committee**, _CUPE 3902_ |

|* Served as the Local’s representative in collaborations with student and labour unions and equity-seeking groups within the University community. 
* Developed allyship with members and non-members in preparation for bargaining as part of the Political Action Committee.
* Managed the Local’s representatives on Joint Health and Safety Committees.
* Advocated for marginalised voices and ensured the Local prioritises the needs of members for inclusive and accessible workplaces.|

2016 - 2020                  | **President (2018-2020) and Vice President (2017-2018) (Elected)** | **Race and Ethnicity Caucus**, _University of Toronto Graduate Students’ Union (UTGSU)_ |

|* Committed to social justice, community building, and healing for self-identified racialized graduate students at the university.
* Organized events, campaigns and initiatives, and collaborated with various on-campus groups to bring awareness to issues that affect BIPOC communities.|

2018 - 2020                  | **Board Member**                                                   | **Student Initiative Fund (SIF)**, _Student Life, University of Toronto_ |

|* Involved in the selection of student-led projects and initiatives that enhance the student experience and foster a sense of community at the university.|


* * *

## Employment

2022 - Present | **Invigilator**          | Accessibility and Testing Services, _University of Toronto_ |

|Supervising students who write tests/exams administered with accommodations based on medical documentation and/or assessment results, and ensuring that students receive the accommodations as outlined by Accessibility Services and that the integrity of the examination process is maintained. Administering tests/exams in accordance with the examination policies and procedures of Accommodated Testing Services and the University of Toronto.|

2018 - 2022 | **Chief Presiding Officer** | Office of the Faculty Registrar, _Faculty of Arts & Science, University of Toronto_ |

|Overseeing the organization examination rooms; managing emergency situations, returning materials to the Office of the Registrar; maintaining the confidentiality of examination materials; and carrying out the directives contained in the procedures and regulations governing UofT Final Examinations.|

2007 - 2014 | **Page**                    | _Toronto Public Library_ |

|Shelved and organized library materials, utilized library databases (CircIT and Symphony), responded to patron research inquiries, provided patrons aid in locating print and online resources.|

Summer 2010 | **Summer Intern**                    | Mobility, Fracture, Multiple Sclerosis, E.N.T. Clinics, _St. Michael’s Hospital_ |

|Co-ordination of patient flow, patient registration, responding to patient inquiries, booking and transferring referrals, preparing and organizing confidential medical documents, answering multiline telephones, and efficiently multitasking. Rotated between different hospital clinics (multiple sclerosis, ear, nose and throat, mobility, and fracture clinics) led to diverse interactions with patients of varying abilities.|

Summer 2009 | **Summer Intern**                    | Diagnostic Laboratories, _St. Michael’s Hospital_ |

|Specimen collection and distribution from clinic to diagnostic laboratory, coordinating flow of specimen for analysis, preparation of buffers and reagents, stocking and maintaining lab supplies.|




[back](./)
